Chinese biotech overtakes AI as top emerging-market growth trade as AI rally sputters

Investors are turning to Chinese biotech as a high-growth alternative while the AI rally falters in emerging markets. The shift reflects a search for new opportunities amid the AI slowdown.

• Chinese Biotech Overtakes AI as Emerging-Market Growth Trade